# Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

> **NCT01906008** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 122 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo
- **BEHAVIORAL:** Questionnaires
- **BEHAVIORAL:** Sensory Test

## Key facts

- **NCT ID:** NCT01906008
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2019-02-14
- **Final completion:** 2019-02-14
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2020-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906008, "Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01906008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*